Enara Bio
Enara Bio is a Healthcare & Life Sciences startup based in France, most recent round Series B, 2 tracked investors.
About Enara Bio
Enara Bio is a startup based in France. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Enara Bio is a biopharmaceutical company pioneering the discovery of novel Dark Antigens and the development of bispecific T-cell engagers for solid tumors. It utilizes its proprietary EDAPT platform to discover cancer-specific targets derived from previously unexplored regions of the genome, known as the 'dark genome', and employs the EnTiCE platform to develop potent immunotherapies.
Explore Enara Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.